HSBC to Sell Singapore Insurance Business to Allianz for $2.1 Billion
By P.R. Venkat
HSBC Holdings has agreed to sell its Singapore life and health insurance business to Allianz for $2.1 billion, as the U.K.-based lender reshapes its portfolio to focus on core markets and businesses.
The sale is expected to generate a pre-tax gain of about $1.8 billion at the HSBC Group consolidated level, the bank said Friday.
Upon completion, HSBC and Allianz will enter into an exclusive 15-year bancassurance partnership that would allow HSBC to continue distributing insurance products to its Singapore customers.
HSBC would receive an initial lump-sum cash payment of $200 million as part of the agreement.
"The transaction forms part of the ongoing simplification of the HSBC Group as it focuses on increasing leadership and market share in the areas where it has a clear competitive advantage and the greatest opportunities to grow and support its clients," HSBC said.
The transaction is expected to close in the first half of 2027, subject to regulatory approvals.
Write to P.R. Venkat at venkat.pr@wsj.com
(END) Dow Jones Newswires
July 23, 2026 19:43 ET (23:43 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
United States